Cargando…
The challenge of HIV treatment in an era of polypharmacy
INTRODUCTION: The availability of potent antiretroviral therapy has transformed HIV infection into a chronic disease such that people living with HIV (PLWH) have a near normal life expectancy. However, there are continuing challenges in managing HIV infection, particularly in older patients, who oft...
Autores principales: | Back, David, Marzolini, Catia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996317/ https://www.ncbi.nlm.nih.gov/pubmed/32011104 http://dx.doi.org/10.1002/jia2.25449 |
Ejemplares similares
-
HIV therapy in an ageing population — the challenge of polypharmacy
por: Back, DJ
Publicado: (2010) -
Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
por: Courlet, Perrine, et al.
Publicado: (2019) -
The Next Therapeutic Challenge in HIV: Polypharmacy
por: Edelman, E. Jennifer, et al.
Publicado: (2013) -
Dexamethasone is a dose-dependent perpetrator of drug–drug interactions: implications for use in people living with HIV
por: Jacobs, Tom G, et al.
Publicado: (2021) -
Fluvoxamine for the treatment of COVID-19
por: Marzolini, Catia, et al.
Publicado: (2022)